# TREACE MED CONCEPTS INC (TMCI)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/TMCI/

- Reporting holders: 3
- Reported value: $37.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $36.0K | 8,098 | 0.0% | 6 |
| [Marquette Asset Management, LLC](https://holderbook.com/funds/1395067-marquette-asset-management-llc/) | $1.6K | 355 | 0.0% | 2 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $186 | 42 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $37.7K |
| Q2 2026 | 121 | $131.9M |
| Q1 2026 | 117 | $48.3M |
| Q4 2025 | 114 | $88.4M |
| Q3 2025 | 120 | $271.2M |
| Q2 2025 | 126 | $226.3M |
| Q1 2025 | 138 | $315.8M |
| Q4 2024 | 135 | $280.3M |
| Q3 2024 | 134 | $243.7M |
| Q2 2024 | 128 | $274.1M |
| Q1 2024 | 131 | $635.6M |
| Q4 2023 | 126 | $573.4M |